Evidence map›Paper›PMID 28247964›Full record

ArticleCancer science2017

PI(3,4)P

Miki Fukumoto, Takeshi Ijuin, Tadaomi Takenawa

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Phosphoinositide Conversion Inactivates R-RAS and Drives Metastases in Breast Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. PI(3,4)PCancer science · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Miki FukumotoThe Integrated Center for Mass Spectrometry, Kobe University Graduate School of Medicine, Kobe, Japan.
Takeshi IjuinDivision of Biochemistry, Kobe University Graduate School of Medicine, Kobe, Japan.ORCID http://orcid.org/0000-0002-0618-1776
Tadaomi TakenawaDivision of Molecular and Cell Biology, Kobe University Graduate School of Medicine, Kobe, Japan.
Kobe University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphoinositides play pivotal roles in the regulation of cancer cell phenotypes. Among them, phosphatidylinositol 3,4-bisphosphate (PI(3,4)P

Indexed as

Breast NeoplasmsCell AdhesionCell Line, TumorFemaleFocal AdhesionsHumansNeoplasm InvasivenessPhosphatidylinositolsPhosphorylationPTEN PhosphohydrolaseSignal TransductionPhosphatidylinositolsphosphoinositide-3,4-bisphosphatePTEN PhosphohydrolasePTEN protein, humanCell invasionfocal adhesionLpdPI(3,4)P2SHIP2

Identifiers

PMID28247964
PMCPMC5448597
OpenAlexW2592037329

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.